{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:23:58Z","timestamp":1793913838968,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Growth hormone (GH) insensitivity syndrome (GHIS) is a rare clinical condition in which production of insulin-like growth factor 1 is blunted and, consequently, postnatal growth impaired. Autosomal-recessive mutations in signal transducer and activator of transcription (STAT5B), the key signal transducer for GH, cause severe GHIS with additional characteristics of immune and, often fatal, pulmonary complications. Here we report dominant-negative, inactivating\n                    <jats:italic>STAT5B<\/jats:italic>\n                    germline mutations in patients with growth failure, eczema, and elevated IgE but without severe immune and pulmonary problems. These STAT5B missense mutants are robustly tyrosine phosphorylated upon stimulation, but are unable to nuclear localize, or fail to bind canonical STAT5B DNA response elements. Importantly, each variant retains the ability to dimerize with wild-type STAT5B, disrupting the normal transcriptional functions of wild-type STAT5B. We conclude that these STAT5B variants exert dominant-negative effects through distinct pathomechanisms, manifesting in milder clinical GHIS with general sparing of the immune system.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-04521-0","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T11:49:02Z","timestamp":1526989742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-9193","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Klammt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien F.","family":"Gevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayne F.","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. David","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Vokurkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-3524","authenticated-orcid":false,"given":"Louise A.","family":"Metherell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron G.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Pf\u00e4ffle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-5809","authenticated-orcid":false,"given":"Mehul T.","family":"Dattani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0517-9049","authenticated-orcid":false,"given":"Vivian","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"4521_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1210\/er.2010-0023","volume":"32","author":"A David","year":"2011","unstructured":"David, A. et al. Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr. Rev. 32, 472\u2013497 (2011).","journal-title":"Endocr. Rev."},{"key":"4521_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/edrv-15-3-369","volume":"15","author":"RG Rosenfeld","year":"1994","unstructured":"Rosenfeld, R. G., Rosenbloom, A. L. & Guevara-Aguirre, J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr. Rev. 15, 369\u2013390 (1994).","journal-title":"Endocr. Rev."},{"key":"4521_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1210\/jc.2003-031033","volume":"89","author":"Z Laron","year":"2004","unstructured":"Laron, Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J. Clin. Endocrinol. Metab. 89, 1031\u20131044 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4521_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0597-13","volume":"16","author":"RM Ayling","year":"1997","unstructured":"Ayling, R. M. et al. A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat. Genet. 16, 13\u201314 (1997).","journal-title":"Nat. Genet."},{"key":"4521_CR5","first-page":"531","volume":"83","author":"K Iida","year":"1998","unstructured":"Iida, K. et al. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. J. Clin. Endocrinol. Metab. 83, 531\u2013537 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4521_CR6","first-page":"1011","volume":"84","author":"K Iida","year":"1999","unstructured":"Iida, K. et al. Functional characterization of truncated growth hormone (GH) receptor- (1-277) causing partial GH insensitivity syndrome with high GH-binding protein. J. Clin. Endocrinol. Metab. 84, 1011\u20131016 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4521_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000314968","volume":"74","author":"J Aisenberg","year":"2010","unstructured":"Aisenberg, J. et al. Atypical growth hormone insensitivity syndrome (GHIS) and severe insulin-like growth factor-I deficiency (IGFD) resulting from compound heterozygous mutations of the GH receptor (GHR), including a novel frameshift mutation affecting the intracellular domain. Horm. Res. Paediatr. 74, 406\u2013411 (2010).","journal-title":"Horm. Res. Paediatr."},{"key":"4521_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/cen.13116","volume":"85","author":"M Takagi","year":"2016","unstructured":"Takagi, M. et al. A novel dominant negative mutation in the intracellular domain of GHR is associated with growth hormone insensitivity. Clin. Endocrinol. (Oxf.). 85, 669\u2013671 (2016).","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"4521_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1210\/js.2016-1119","volume":"1","author":"K Vairamani","year":"2017","unstructured":"Vairamani, K. et al. Novel dominant-negative GH receptor mutations expands the spectrum of GHI and IGF-I deficiency. J. Endocr. Soc. 1, 345\u2013358 (2017).","journal-title":"J. Endocr. Soc."},{"key":"4521_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa022926","volume":"349","author":"EM Kofoed","year":"2003","unstructured":"Kofoed, E. M. et al. Growth-hormone insensitivity (GHI) associated with a STAT-5b mutation. N. Engl. J. Med. 349, 1139\u20131147 (2003).","journal-title":"N. Engl. J. Med."},{"key":"4521_CR11","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.4049\/jimmunol.177.5.2770","volume":"177","author":"AC Cohen","year":"2006","unstructured":"Cohen, A. C. et al. Cutting edge: decreased accumulation and regulatory function of CD4 + CD25high T cells in human STAT5b deficiency. J. Immunol. 177, 2770\u20132774 (2006).","journal-title":"J. Immunol."},{"key":"4521_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10875-015-0145-5","volume":"35","author":"L Bezrodnik","year":"2015","unstructured":"Bezrodnik, L. et al. Long-term follow-up of STAT5B deficiency in three Argentinian patients: clinical and immunological features. J. Clin. Immunol. 35, 264\u2013272 (2015).","journal-title":"J. Clin. Immunol."},{"key":"4521_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","volume":"28","author":"V Hwa","year":"2016","unstructured":"Hwa, V. STAT5B deficiency: impacts on human growth and immunity. Growth Horm. IGF Res. 28, 16\u201320 (2016).","journal-title":"Growth Horm. IGF Res."},{"key":"4521_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1530\/EJE-15-0398","volume":"173","author":"RC Scalco","year":"2015","unstructured":"Scalco, R. C. et al. STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritability. Eur. J. Endocrinol. 173, 291\u2013296 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"4521_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9470","volume":"6","author":"MJ Kiel","year":"2015","unstructured":"Kiel, M. J. et al. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome. Nat. Commun. 6, 8470 (2015).","journal-title":"Nat. Commun."},{"key":"4521_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk, C. et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat. Commun. 6, 6025 (2015).","journal-title":"Nat. Commun."},{"key":"4521_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat. Genet. 47, 1061\u20131066 (2015).","journal-title":"Nat. Genet."},{"key":"4521_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000338462","volume":"77","author":"JM Wit","year":"2012","unstructured":"Wit, J. M. et al. Genetic analysis of short children with apparent growth hormone insensitivity. Horm. Res. Paediatr. 77, 320\u2013333 (2012).","journal-title":"Horm. Res. Paediatr."},{"key":"4521_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000355928","volume":"80","author":"MJ Walenkamp","year":"2013","unstructured":"Walenkamp, M. J. et al. Genetic analysis of GHR should contain sequencing of all coding exons and specific intron sequences, and screening for exon deletions. Horm. Res. Paediatr. 80, 406\u2013412 (2013).","journal-title":"Horm. Res. Paediatr."},{"key":"4521_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.beem.2010.09.003","volume":"25","author":"V Hwa","year":"2011","unstructured":"Hwa, V., Nadeau, K., Wit, J. M. & Rosenfeld, R. G. STAT5b deficiency: lessons from STAT5b gene mutations. Best. Pract. Res. Clin. Endocrinol. Metab. 25, 61\u201375 (2011).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"4521_CR21","doi-asserted-by":"publisher","first-page":"E830","DOI":"10.1210\/jc.2011-2554","volume":"97","author":"PA Scaglia","year":"2012","unstructured":"Scaglia, P. A. et al. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease. J. Clin. Endocrinol. Metab. 97, E830\u2013E839 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4521_CR22","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1242\/jcs.123042","volume":"126","author":"HY Shin","year":"2013","unstructured":"Shin, H. Y. & Reich, N. C. Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal. J. Cell Sci. 126, 3333\u20133343 (2013).","journal-title":"J. Cell Sci."},{"key":"4521_CR23","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635\u20131648 (2011).","journal-title":"J. Exp. Med."},{"key":"4521_CR24","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1073\/pnas.0501063102","volume":"102","author":"M Zhong","year":"2005","unstructured":"Zhong, M. et al. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc. Natl. Acad. Sci. USA 102, 3966\u20133971 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4521_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","volume":"36","author":"M Depner","year":"2016","unstructured":"Depner, M. et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J. Clin. Immunol. 36, 73\u201384 (2016).","journal-title":"J. Clin. Immunol."},{"key":"4521_CR26","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1182\/blood-2016-02-702373","volume":"128","author":"CE Bocchini","year":"2016","unstructured":"Bocchini, C. E. et al. Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome. Blood 128, 3061\u20133072 (2016).","journal-title":"Blood"},{"key":"4521_CR27","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1220098110","volume":"110","author":"S Hambleton","year":"2013","unstructured":"Hambleton, S. et al. STAT2 deficiency and susceptibility to viral illness in humans. Proc. Natl. Acad. Sci. USA 110, 3053\u20133058 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4521_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","volume":"125","author":"M Yildiz","year":"2015","unstructured":"Yildiz, M. et al. Activating STAT6 mutations in follicular lymphoma. Blood 125, 668\u2013679 (2015).","journal-title":"Blood"},{"key":"4521_CR29","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland, S. M. et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357, 1608\u20131619 (2007).","journal-title":"N. Engl. J. Med."},{"key":"4521_CR30","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi, Y. et al. Dominant-negative mutations in the DNA-binding domains of STAT3 cause hyper-IgE syndrome. Nature 448, 1058\u20131062 (2007).","journal-title":"Nature"},{"key":"4521_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"ED Renner","year":"2008","unstructured":"Renner, E. D. et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J. Allergy Clin. Immunol. 122, 181\u2013187 (2008).","journal-title":"J. Allergy Clin. Immunol."},{"key":"4521_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","volume":"126","author":"LF Schimke","year":"2010","unstructured":"Schimke, L. F. et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J. Allergy Clin. Immunol. 126, 611\u2013617 e611 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"4521_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0092-8674(00)81443-9","volume":"93","author":"X Chen","year":"1998","unstructured":"Chen, X. et al. Crystal Structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93, 827\u2013839 (1998).","journal-title":"Cell"},{"key":"4521_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/28101","volume":"394","author":"S Becker","year":"1998","unstructured":"Becker, S., Groner, B. & Muller, M. Three-dimensional structure of the STAT3 beta homodimer bound to DNA. Nature 394, 145\u2013151 (1998).","journal-title":"Nature"},{"key":"4521_CR35","doi-asserted-by":"publisher","first-page":"13015","DOI":"10.1073\/pnas.1611228113","volume":"113","author":"J Li","year":"2016","unstructured":"Li, J. et al. Structural basis for DNA recognition by STAT6. Proc. Natl. Acad. Sci. USA 113, 13015\u201313020 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4521_CR36","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1210\/en.2008-0985","volume":"150","author":"EF Gevers","year":"2009","unstructured":"Gevers, E. F., Hannah, M. J., Waters, M. J. & Robinson, I. C. Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. Endocrinology 150, 3627\u20133636 (2009).","journal-title":"Endocrinology"},{"key":"4521_CR37","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter, E. J. et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365, 1054\u20131061 (2005).","journal-title":"Lancet"},{"key":"4521_CR38","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James, C. et al. A unique cloncal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434, 1144\u20131148 (2005).","journal-title":"Nature"},{"key":"4521_CR39","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics, R. et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352, 1779\u20131790 (2005).","journal-title":"N. Engl. J. Med."},{"key":"4521_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clim.2013.04.014","volume":"148","author":"JA Jenks","year":"2013","unstructured":"Jenks, J. A. et al. Differentiating the roles of STAT5B and STAT5A in human CD4 + T cells. Clin. Immunol. 148, 227\u2013236 (2013).","journal-title":"Clin. Immunol."},{"key":"4521_CR41","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jpeds.2010.12.042","volume":"158","author":"K Nadeau","year":"2011","unstructured":"Nadeau, K., Hwa, V. & Rosenfeld, R. G. STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J. Pediatr. 158, 701\u2013708 (2011).","journal-title":"J. Pediatr."},{"key":"4521_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ghir.2012.02.005","volume":"22","author":"Z Laron","year":"2012","unstructured":"Laron, Z., Iluz, M. & Kauli, R. Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency. Growth Horm. IGF Res. 22, 49\u201352 (2012).","journal-title":"Growth Horm. IGF Res."},{"key":"4521_CR43","doi-asserted-by":"publisher","first-page":"E1428","DOI":"10.1210\/jc.2013-1534","volume":"98","author":"SR Wang","year":"2013","unstructured":"Wang, S. R. et al. Large scale pooled next-generation sequencing of 1077 genes to identify causes of short stature. J. Clin. Endocrinol. Metab. 98, E1428\u20131437 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4521_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/EJE-14-0541","volume":"172","author":"HL Storr","year":"2015","unstructured":"Storr, H. L., Dunkel, L., Kowalczyk, J., Savage, M. O. & Metherell, L. A. Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation. Eur. J. Endocrinol. 172, 151\u2013161 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"4521_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/EJE-17-0453","volume":"177","author":"L Shapiro","year":"2017","unstructured":"Shapiro, L. et al. Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity. Eur. J. Endocrinol. 177, 485\u2013501 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"4521_CR46","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1507\/endocrj.EJ17-0150","volume":"64","author":"A Hattori","year":"2017","unstructured":"Hattori, A. et al. Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature. Endocr. J. 64, 947\u2013954 (2017).","journal-title":"Endocr. J."},{"key":"4521_CR47","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","volume":"121","author":"HL Rajala","year":"2013","unstructured":"Rajala, H. L. et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood 121, 4541\u20134550 (2013).","journal-title":"Blood"},{"key":"4521_CR48","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","volume":"128","author":"EI Andersson","year":"2016","unstructured":"Andersson, E. I. et al. High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia. Blood 128, 2465\u20132468 (2016).","journal-title":"Blood"},{"key":"4521_CR49","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat. Genet. 49, 1211\u20131218 (2017).","journal-title":"Nat. Genet."},{"key":"4521_CR50","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0092-8674(00)81444-0","volume":"93","author":"S Teglund","year":"1998","unstructured":"Teglund, S. et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841\u2013850 (1998).","journal-title":"Cell"},{"key":"4521_CR51","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1182\/blood-2006-11-055756","volume":"109","author":"Z Yao","year":"2007","unstructured":"Yao, Z. et al. Nonredundant roles for STAT5a\/b in directly regulating Foxp3. Blood 109, 4368\u20134375 (2007).","journal-title":"Blood"},{"key":"4521_CR52","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"4521_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"4521_CR54","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1074\/jbc.M310495200","volume":"279","author":"V Hwa","year":"2004","unstructured":"Hwa, V., Little, B., Kofoed, E. M. & Rosenfeld, R. G. Transcriptional regulation of insulin-like growth factor-I (IGF-I) by interferon-gamma (IFN-g) requires Stat-5b. J. Biol. Chem. 279, 2728\u20132736 (2004).","journal-title":"J. Biol. Chem."},{"key":"4521_CR55","doi-asserted-by":"publisher","first-page":"14791","DOI":"10.1074\/jbc.274.21.14791","volume":"274","author":"M Maamra","year":"1999","unstructured":"Maamra, M. et al. Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of JAK2-Stat5 signaling. J. Biol. Chem. 274, 14791\u201314798 (1999).","journal-title":"J. Biol. Chem."},{"key":"4521_CR56","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2005-2558","volume":"91","author":"P Fang","year":"2006","unstructured":"Fang, P. et al. A mutant signal transducer and activator of transcription 5B, associated with growth hormone insensitivity and insulin-like growth factor-I deficiecny, cannot function as a signal transducer or transcription factor. J. Clin. Endocrinol. Metab. 91, 1526\u20131534 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4521_CR57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1210\/me.2012-1275","volume":"27","author":"B Varco-Merth","year":"2013","unstructured":"Varco-Merth, B. et al. Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity. Mol. Endocrinol. 27, 150\u2013161 (2013).","journal-title":"Mol. Endocrinol."},{"key":"4521_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/jc.2002-020510","volume":"88","author":"M Friedberg","year":"2003","unstructured":"Friedberg, M. et al. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. J. Clin. Endocrinol. Metab. 88, 385\u2013393 (2003).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04521-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T09:08:24Z","timestamp":1671527304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04521-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["4521"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-04521-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"2 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.G.R. consults for OPKO, Versartis, Ascendis, Genexine, Ammonite, Sandoz, Ferring, and NovoNordisk. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2105"}}